Dengue and chikungunya, the two mosquito-borne diseases that frequently circulate at the same time, share the same Aedes ...

Shield’s FDA-approved blood test drives cancer screening growth, pricing power, and cash-flow upside. Click for this GH ...

Rheumatologists share how they are using AI platforms for clinical documentation, reducing EHR time, streamlining workflows, ...

Tempus AI, Inc. , a technology company leading the adoption of AI to advance precision medicine, today announced results from a new study demonstrating that its algorithmic test, Immune Profile Score ...

AI Nose integration positions robotics application as a scalable growth engineMirle partnership expands SmellTech robotics into industrial environments HOUSTON, TEXAS / ACCESS Newswire / February 5, 2 ...

AI Nose advances through a dual-engine architecture, enabling scalable deploymentsIndustrial and semiconductor deployments broaden Ainos' commercial footprintRobotics momentum accelerates data flywhee ...

QT Imaging Holdings, Inc. ("QT Imaging" or the "Company"), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today ...

From hacking hot flashes to postponing menopause altogether, here’s what’s on the horizon.

Objectives Female sex and anticitrullinated protein antibodies (ACPA) are associated with higher disease activity in ...

Propelled by encouraging regulatory reforms since 2014, India is fast emerging as a much sought-after destination for global clinical trials. Streamlined approval timelines, clearer ethical guidelines ...

Well, the first half of 2025 certainly threw a bit of a curveball at the pharma and biotech sectors. Despite a steady stream of new drug approvals and ongoing innovation, things didn’t quite follow ...

FDA officials are advising drug developers to study the long-term effects of using CAR-T in autoimmune conditions out of ...